A typical ligand of the receptor pathway involved in the selective induction of cancer cell apoptosis is TRAIL, which works by binding specific surface receptors located on target cells—TRAIL-R1 (DR4) and TRAIL-R2 (DR5). Here, TNFRSF10A is linked to cancer.